Effect of add on aripiprazole on antipsychotic induced hyperprolactinemia

被引：0
|
作者：
Kg, V. Kumar [1 ]
Venkatasubramanian, G. [1 ]
Varambally, S. [1 ]
机构：
[1] NIMHANS, Bengaluru, India
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2014年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-25-031
引用
收藏
页码：108 / 108
页数：1
相关论文
共 50 条
  • [1] Add-on aripiprazole for atypical antipsychotic-induced, clinically significant hyperprolactinemia
    Raveendranthan, Dhanya
    Rao, Naren P.
    Rao, Mukund G.
    Mangot, Ajish G.
    Varambally, Shivaram
    Kesavan, Muralidharan
    Venkatasubramanian, Ganesan
    Gangadhar, Bangalore N.
    INDIAN JOURNAL OF PSYCHOLOGICAL MEDICINE, 2018, 40 (01) : 38 - 40
  • [2] A comment on "add-on aripiprazole for atypical antipsychotic-induced, clinically significant hyperprolactinemia"
    Naguy, Ahmed
    INDIAN JOURNAL OF PSYCHOLOGICAL MEDICINE, 2018, 40 (03) : 299 - 300
  • [3] Reversal of symptomatic antipsychotic-induced hyperprolactinemia with addition of aripiprazole
    Paraskevi Kotorki
    Parthena Pelka
    Christina Leotsakou
    Aikaterini Kalogeropoulou
    Markella Fiste
    Georgios Vagionis
    Anastasia Roussi
    Periklis Paterakis
    Annals of General Psychiatry, 9 (Suppl 1)
  • [4] Aripiprazole for the Treatment of Antipsychotic-Induced Hyperprolactinemia in an Adolescent Boy
    Curran, Rebecca L.
    Badran, Ismail A.
    Peppers, Virginia
    Pedapati, Ernest V.
    Correll, Christoph U.
    DelBello, Melissa P.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2016, 26 (05) : 490 - 491
  • [5] Adjunctive treatment with a dopamine partial agonist, aripiprazole for antipsychotic induced hyperprolactinemia
    Shim, J. C.
    Kelly, D. L.
    Jung, D. U.
    Seo, Y. S.
    Kim, Y. H.
    Conley, R. R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S405 - S406
  • [6] Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: A pilot study
    Lee, Bun-Hee
    Kim, Yong-Ku
    Park, Sun-Hwa
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2006, 30 (04): : 714 - 717
  • [7] Comparison between addition of and switching to aripiprazole for resolving antipsychotic-induced hyperprolactinemia
    Lee, Jung Suk
    Lee, Byung Ook
    Yoon, Hui Woo
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 196 - 196
  • [8] Potential control of antipsychotic-induced hyperprolactinemia and obesity in children and adolescents by aripiprazole
    Lian, Jiamei
    Huang, Xu-Feng
    Pai, Nagesh
    Deng, Chao
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (06): : 1157 - 1158
  • [9] Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole
    Lu, Mong-Liang
    Shen, Winston W.
    Chen, Chun-Hsin
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (08): : 1978 - 1981
  • [10] Reversal of antipsychotic-induced hyperprolactinemia, weight gain, and dyslipidemia by aripiprazole: A case report
    Lin, Shih-Ku
    Chen, Chih-Ken
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (08) : 1307 - 1307
12345